*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Nate Dwarshuis
BME PhD Proposal Presentation
Date: May 7th, 2019
Time: 12:00 PM
Location: EBB 5029
Advisor: Krishnendu Roy (Georgia Institute of Technology)
Committee Members:
Madhav Dhodapkar (Emory University)
Melissa Kemp (Georgia Institute of Technology)
Wilbur Lam (Georgia Institute of Technology)
Sakis Mantalaris (Georgia Institute of Technology)
Title: Optimizing T Cell Manufacturing and Quality Using Functionalized Microcarriers
Abstract/Summary:
Adoptive cell therapies (ACT) using chimeric antigen receptor (CAR) T cells have shown promise in treating cancer, but manufacturing large numbers of high quality cells remains challenging. Critically, current T cell expansion technologies only partially recapitulate the in vivo microenvironment found in the human lymph nodes. In these organs, T cells expand at high cell density with autocrine/paracrine signaling, as well as signals from the extracellular matrix (ECM). Here we propose a T cell expansion system using degradable gelatin microcarriers functionalized with anti-CD3 and anti-CD28 monoclonal antibodies (mAbs), which address several of these shortcomings by providing a 3D surface on which T cells can cluster at high cell density and remain in contact with ECM components.
The overall objective of this proposal will be to develop this microcarrier platform into a controllable process that can conceivably be used in industry. We will do this in three aims: 1) Develop a novel microcarrier platform and assess its performance relative to current state-of-the-art T cell expansion technology, 2) optimize the microcarrier system for in vivo performance using a design of experiments (DOE) approach, and 3) characterize microcarrier- expanded T cell of differing performance using multiomics techniques to generate predictive models. The result of these three aims will be a platform for expanding T cells and an accompanying set of mathematical models that can be used to predict and control process outcomes.
